Patent Yard Sign in
Canadian application, no grantCanada

Application of tnf antagonists as medicaments for treating septic diseases

CA 2306790 A1 · Owner: Kaul, Martin · Inventors: Daum, Lothar; Kempeni, Joachim; Eiselstein, Jurgen

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to the application of TNF antagonists in order to produce medicaments for treating septic diseases characterized by an increasing coarse of the interleukin-6 serum level during a measurement interval of at least thirty minutes.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 15, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 15, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 15, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 15, 1998
GrantedNo grant recorded
Term endedOctober 15, 2018
Patent numberCA 2306790 A1
Classification (IPC)A61K39/39 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedOct 15, 1998Term endedOct 15, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.